Alnylam

Management

John M. Maraganore, Ph.D.
Chief Executive Officer and Director
Barry Greene
President and Chief Operating Officer
Akshay Vaishnaw, M.D., Ph.D.
Executive VP of R&D and Chief Medical Officer
Oved Amitay
VP, Head of Commercial
Karen Anderson
SVP, Chief Human Resources Officer
Steve Bossone, Ph.D.
VP, Intellectual Property
Jeff Cehelsky
VP, Clinical Operations
Mary Beth Delena
VP, Associate General Counsel
Kevin Fitzgerald Ph.D.
VP, Research
John Frenz Ph.D.
VP, Manufacturing
Pritesh Gandhi
VP, Medical Affairs
Pushkal Garg M.D.
SVP, Clinical Development
Jared Gollob M.D.
VP, Clinical Research
Eric Green
VP, General Manager, TTR Program
Susanna High
SVP Strategy and Business Integration
Laurie Keating
SVP, General Counsel and Secretary
Mark Kozul, M.D.
VP, Strategy
Muthiah Manoharan, Ph.D.
SVP, Drug Discovery
Michael Mason
VP. Finance & Treasurer
Rachel Meyers, Ph.D.
SVP, Research
Lubomir Nechev, Ph.D.
VP, Process Sciences
Sara Nochur, Ph.D.
SVP, Regulatory Affairs
Michael Placke, Ph.D. DABT
SVP, Drug Safety and Metabolism
Marcie Ruddy M.D.
VP, Drug Safety & Pharmacovigilance
Aria Tavana, Ph.D.
VP, Quality Assurance
Laura Sepp-Lorenzino
VP, Entrepreneur-in-Residence